This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Philips Showcases Integrated Diagnostic, Therapy And Compliance Solutions At SLEEP 2014

Stocks in this article: PHG

ANDOVER, Mass., June 2, 2014 /PRNewswire/ --  Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase its latest sleep-disordered breathing solutions June 1-4 at SLEEP 2014, the 28th Annual Meeting of the Associated Professional Sleep Societies LLC (APSS).

Royal Philips

Philips will present innovations that span the continuum of care, helping to diagnose, treat and manage sleep disorders. Physicians will have the opportunity to see new options in home sleep testing, CPAP masks, and programs that enhance patient engagement and long-term care.

"Evidence shows that motivated, educated patients embrace therapy and participate more fully in their own care," says Teofilo Lee Chiong, M.D., Chief Medical Liaison, Philips Healthcare. "Philips is creating an ecosystem of medical devices and services, using smart technology, to empower patients and advance the effectiveness of sleep therapy."

At SLEEP 2014 in Minneapolis, MN, Philips will spotlight the following products and services that are part of the industry's broadest portfolio of insight-driven solutions.

Easy and reliable sleep testing in the home

The Alice NightOne home sleep testing system, which Philips will preview at SLEEP 2014, is making home sleep testing (HST) easy for patients and sleep professionals.

  • Intuitive design and a "smart guide" enable patients to set up the device on their own with confidence.
  • "Good Study Indicator" visually displays the amount of quality data in 25 percent increments, allowing the clinician to decide if the patient needs to repeat the study before returning the device.
  • Provides reliable data to differentiate between obstructive, central and positional sleep apnea.

Professional sleep and activity monitoring solutions

The Actiwatch Spectrum Plus and Actiwatch Spectrum PRO data collection devices provide accurate and objective activity, sleep, wake and light-exposure data.

  • Collects data on a variety of sleep parameters, 24/7, with advanced sensing capabilities.
  • Wristwatch functionality offers convenience for the wearer.
  • Actiwatch Spectrum PRO includes subjective scoring capabilities and audible and vibrational alarms.

Mask options as unique as each patient

Comfort is key to obstructive sleep apnea (OSA) patients using PAP therapy, and Philips' mask options account for the unique facial structure and breathing preferences. For the first time at the SLEEP conference, Philips' entire new mask lineup is available for attendees to see and experience.

  • Nuance and Nuance Pro, rated by patients as easier to assemble and use than the leading pillows mask.
  • Amara silicone and gel masks, both smaller and lighter than the current leading full face mask, with 60% fewer parts.
  • Wisp, which combines the performance and comfort of a nasal mask with the aesthetics of a pillows mask.

Patient engagement and long-term care supportThe SleepMapper mobile and web-based self-management application is enabling patients to take a more active role in their therapy by providing vital support to those with OSA. The results of a study released at SLEEP 2014 show that patients using SleepMapper achieved a PAP therapy adherence rate that was 22% higher than non-users.

  • Works with EncoreAnywhere and most System One devices to provide a complete therapy and compliance solution.
  • Offers clinicians and home care providers multiple ways to connect to their patients, ensuring needed therapy support, efficient resupply, and ultimately, enhanced PAP adherence.

Bluetooth connectivity to assist patients and their care team

Philips will preview the System One Sleep therapy device with integrated Bluetooth technology. 

  • Combined with the EncoreAnywhere data management system, integrated Bluetooth technology provides OSA patients with a simple way to retrieve their PAP data through the SleepMapper self-management solution.
  • Offers homecare providers a cost-effective option for retrieving compliance information.

Visit booth #600 to see Philips Respironics' latest diagnostic, therapy, and compliance solutions. To learn how Philips is improving the quality of healthcare through innovative solutions, inspired by human insights, visit www.philips.com/healthcare and follow the #SLEEP2014 conversation @PhilipsResp.

For further information, please contact: Alicia CafardiPhilips HealthcareTel: +1 724-387-4439E-mail: alicia.cafardi@philips.com

About Royal Philips: Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 112,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

SOURCE Royal Philips

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs